Over the 90-day window ending February 07, 2026, Maze Therapeutics's three dominant insider ownership positions are held by TenPercentOwner Rock Ventures Iv, L.P. Third (5.42Mn shares), Director Jonathan E Lim (307.96K shares), Director Charles J Homcy (38.53K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Rock Ventures Iv, L.P. Third | 5,424,758 | 05 Nov, 2025 | |
| Jonathan E Lim | 307,956 | 04 Feb, 2025 | |
| Charles J Homcy | 38,535 | 21 Nov, 2025 | |
| Amy Bachrodt | Svp And Finance | 12,965 | 04 Feb, 2026 |
| Atul Dandekar | Csbo | 10,503 | 02 Feb, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Feb, 2026 | Harold Bernstein | Common Stock | D | 600 | $44.20 | 14,400 | D | S |
| 02 Feb, 2026 | Harold Bernstein | Common Stock | D | 8,364 | $45.89 | 6,036 | D | S |
| 02 Feb, 2026 | Harold Bernstein | Common Stock | D | 100 | $47.23 | 0 | D | S |
| 02 Feb, 2026 | Harold Bernstein | Common Stock | A | 15,000 | $10.42 | 15,000 | D | M |
| 02 Feb, 2026 | Harold Bernstein | Common Stock | D | 5,936 | $46.37 | 100 | D | S |
| 02 Feb, 2026 | Amy Bachrodt | Common Stock | A | 156 | $10.42 | 17,965 | D | M |
| 02 Feb, 2026 | Amy Bachrodt | Common Stock | D | 200 | $44.15 | 17,765 | D | S |
| 02 Feb, 2026 | Amy Bachrodt | Common Stock | A | 4,844 | $10.42 | 17,809 | D | M |
| 02 Feb, 2026 | Amy Bachrodt | Common Stock | D | 736 | $46.63 | 12,965 | D | S |
| 02 Feb, 2026 | Amy Bachrodt | Common Stock | D | 4,064 | $46.03 | 13,701 | D | S |
| 29 Jan, 2026 | Atul Dandekar | Common Stock | D | 2,800 | $45.01 | 10,503 | D | S |
| 29 Jan, 2026 | Atul Dandekar | Common Stock | D | 1,200 | $43.18 | 16,803 | D | S |
| 29 Jan, 2026 | Atul Dandekar | Common Stock | A | 7,500 | $10.42 | 18,003 | D | M |
| 29 Jan, 2026 | Atul Dandekar | Common Stock | D | 3,500 | $44.04 | 13,303 | D | S |
| 22 Jan, 2026 | Amy Bachrodt | Common Stock | A | 2,503 | $10.42 | 17,965 | D | M |
| 22 Jan, 2026 | Amy Bachrodt | Common Stock | D | 5,000 | $45.52 | 12,965 | D | S |
| 22 Jan, 2026 | Amy Bachrodt | Common Stock | A | 2,497 | $10.42 | 15,462 | D | M |
| 07 Jan, 2026 | Catherine A. Sohn | Common Stock | A | 3,281 | $10.42 | 26,920 | D | M |
| 07 Jan, 2026 | Catherine A. Sohn | Common Stock | A | 20,744 | $10.42 | 20,744 | D | M |
| 07 Jan, 2026 | Catherine A. Sohn | Common Stock | A | 2,895 | $10.42 | 23,639 | D | M |